WallStSmart

Revolution Medicines Inc (RVMD)vsWoodside Energy Group Ltd (WDS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Woodside Energy Group Ltd generates 1749765% more annual revenue ($12.98B vs $742,000). WDS leads profitability with a 20.9% profit margin vs 0.0%. WDS earns a higher WallStSmart Score of 53/100 (C-).

RVMD

Avoid

24

out of 100

Grade: F

Growth: 3.7Profit: 3.0Value: 5.0Quality: 7.3
Piotroski: 2/9Altman Z: 3.27

WDS

Buy

53

out of 100

Grade: C-

Growth: 2.0Profit: 6.0Value: 8.0Quality: 4.8
Piotroski: 2/9Altman Z: 1.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for RVMD.

WDSUndervalued (+31.5%)

Margin of Safety

+31.5%

Fair Value

$27.39

Current Price

$21.57

$5.82 discount

UndervaluedFair: $27.39Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

RVMD1 strengths · Avg: 10.0/10
Altman Z-ScoreHealth
3.2710/10

Safe zone — low bankruptcy risk

WDS3 strengths · Avg: 9.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Profit MarginProfitability
20.9%9/10

Keeps 21 of every $100 in revenue as profit

P/E RatioValuation
15.4x8/10

Attractively priced relative to earnings

Areas to Watch

RVMD4 concerns · Avg: 3.5/10
Price/BookValuation
17.1x4/10

Trading at 17.1x book value

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Operating MarginProfitability
0.0%3/10

Operating margin of 0.0%

WDS4 concerns · Avg: 2.5/10
Return on EquityProfitability
7.2%3/10

ROE of 7.2% — below average capital efficiency

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Revenue GrowthGrowth
-11.1%2/10

Revenue declined 11.1%

EPS GrowthGrowth
-14.4%2/10

Earnings declined 14.4%

Comparative Analysis Report

WallStSmart Research

Bull Case : RVMD

The strongest argument for RVMD centers on Altman Z-Score.

Bull Case : WDS

The strongest argument for WDS centers on Price/Book, Profit Margin, P/E Ratio. Profitability is solid with margins at 20.9% and operating margin at 19.1%. PEG of 1.33 suggests the stock is reasonably priced for its growth.

Bear Case : RVMD

The primary concerns for RVMD are Price/Book, EPS Growth, Profit Margin.

Bear Case : WDS

The primary concerns for WDS are Return on Equity, Piotroski F-Score, Revenue Growth.

Key Dynamics to Monitor

RVMD profiles as a value stock while WDS is a declining play — different risk/reward profiles.

RVMD carries more volatility with a beta of 1.41 — expect wider price swings.

WDS is growing revenue faster at -11.1% — sustainability is the question.

WDS generates stronger free cash flow (417M), providing more financial flexibility.

Bottom Line

WDS scores higher overall (53/100 vs 24/100), backed by strong 20.9% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Revolution Medicines Inc

HEALTHCARE · BIOTECHNOLOGY · USA

Revolution Medicines, Inc., a precision clinical-stage oncology company, is focused on developing therapies to inhibit borderline targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.

Woodside Energy Group Ltd

ENERGY · OIL & GAS E&P · USA

Woodside Energy Group Ltd is engaged in the exploration, evaluation, development, production, marketing and sale of hydrocarbons in Oceania, Asia, Canada, Africa and internationally. The company is headquartered in Perth, Australia.

Want to dig deeper into these stocks?